What we may expect from novel antibacterial agents in the pipeline with respect to resistance and pharmacodynamic principles
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology
Link
http://link.springer.com/content/pdf/10.1007/s10928-017-9506-4.pdf
Reference176 articles.
1. Projan SJ, Shlaes DM (2004) Antibacterial drug discovery: is it all downhill from here? Clin Microbiol Infect 4:18–22
2. Tomayko JF, Rex JH, Tenero DM, Goldberger M, Eisenstein BI (2014) The challenge of antimicrobial resistance: new regulatory tools to support product development. Clin Pharmacol Ther 96(2):166–168
3. Boucher HW, Talbot GH, Benjamin DK, Bradley J, Guidos RJ, Jones RN, Murray BE, Bonomo RA, Gilbert D (2013) 10 × ’20 Progress—development of new drugs active against Gram-negative bacilli: an update from the Infectious Diseases Society of America. Clin Infect Dis 56(12):1685–1694
4. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48(1):1–12
5. CDC (2013) Antibiotic resistance threats in the United States, 2013. CDC, Atlanta
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Arg-biodynamers as antibiotic potentiators through interacting with Gram-negative outer membrane lipopolysaccharides;European Journal of Pharmaceutics and Biopharmaceutics;2024-07
2. Predicting permeation of compounds across the outer membrane of P. aeruginosa using molecular descriptors;Communications Chemistry;2024-04-12
3. Rapid AMR prediction in Pseudomonas aeruginosa combining MALDI–TOF MS with DNN model;Journal of Applied Microbiology;2023-11-01
4. Repurposing FDA approved drug molecules against A B C classes of β-lactamases: a computational biology and molecular dynamics simulations study;Journal of Biomolecular Structure and Dynamics;2023-11
5. Predicting Permeation of Compounds across the Outer Membrane ofP. aeruginosaUsing Molecular Descriptors: Advantages and Limitations;2023-09-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3